Search results
  1. 17 hours ago

    Glory to God. Eleven years cancer free today from kidney cancer.

    3 replies 4 likes
  2. Sep 10

    9% Complete Response and OS benefit in metastatic at Great news for patients! But maybe not for everyone!

    5 retweets 5 likes
  3. Sep 9

    Introduction to and team from

    1 retweet
  4. Sep 10

    Big meeting for : CABOSUN + PFS by IR, C.Porta states very credible 1L option in int/poor risk

    7 retweets 11 likes
  5. Sep 9

    during the

    1 retweet 1 like
  6. Sep 9

    Removing the tumor.

    1 retweet 2 likes
  7. Sep 9

    Conclusions by Axel Bex on SURTIME trial - immediate vs. deferred surgery affer sunitinib for metastatic

    1 reply 31 retweets 46 likes
  8. Sep 10

    New first line therapy for metastatic . Ipi/nivo shows 9% CR!

    2 replies 8 retweets 17 likes
  9. Sep 9

    TFE3 translocationRCC(with confirmatoryFISH) which looks like clear cellRCC-psammoma bodies the clue to workup/diagnosis here

    13 retweets 18 likes
  10. Sep 4

    Pres.Symp.II CHECKMATE214 DrEscudier&Motzer

    1 reply 9 retweets 8 likes
  11. Sep 7

    Ipi/nivo beats sunitinib in 1L by OS. reports on phase 3 trial primary endpoint results

    5 retweets 6 likes
  12. Sep 10

    Four countries. One advocacy mission: collaborating to reduce the global burden of

    Amazing international team collaborating on
    3 retweets 6 likes
  13. Sep 7

    Breaking news today in the world of ; more details at on Saturday +nivo combination as 1st line treatment

    : Report of primary endpoint results in Phase 3 trial in renal cell carcinoma
    6 retweets 8 likes
  14. 12 hours ago

    For patient community: "immature" data means patients are still alive. Appreciate their contribution to research!

    ADAPT Ph3 trial in mRCC (Rocapuldemcel-T): negative study but still immature and probably hypothesis generating
    4 retweets 8 likes
  15. Sep 10

    Breaking news - Checkmate-214 big ⬆️OS with ipi+NIVO in 1st line mRCC - note benefit PD-L1>1% and int/poor risk groups

    2 replies 5 retweets 10 likes
  16. 5 hours ago

    begins in the kidneys--two bean-shaped organs on each side of your spine

    2 retweets 3 likes
  17. 9 hours ago

    How long is enough? When to discontinue -oncology treatment= unmet need for in

    Dr Caroline Robert on "When to Discontinue Immunotherapy" Lack of regulation an open door for pt advocates to weigh in?
    5 retweets 2 likes
  18. 16 hours ago

    Management of upper urinary tract urothelial carcinoma

    3 retweets 5 likes
  19. Sep 10

    Impressive activity of nivolumab + ipilumab on treatment naive metastatic - 9% complete response in int-poor risk pts

    8 retweets 10 likes
  20. Sep 10

    Dr Bernard Escudier on Checkmate-214 data: extends his sincere appreciation to hundreds of patients worldwide

    9 retweets 20 likes

No results.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.